BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VEVENT UID:b9060667613bbb1fcbe53ea7fbfef70c CATEGORIES:Colloquium CREATED:20201217T134835 SUMMARY:Morteza Mahmoudi, Michigan State University DESCRIPTION:
NanoBio Interfaces: Opportunities and Challenges of Protein C orona
Nanoparticles (NPs) are be coming increasingly promising tools for medical diagnostics and therapeutic s. Despite the advances in their biomedical applications and numerous publi cations, fewer than expected NPs have made it to clinical trials and even f ewer have reached clinical practice. This wide gap between bench discoverie s and clinical applications is mainly because of our limited understanding of the nanobiointerfaces. Although extensive studies have been conducted to enhance our understanding of the nanobiointerfaces, the literature remains unclear and contains conflicting information, even for seemingly identical NPs. The main goal of this talk is to introduce some of the existing “over looked” factors at the nanobiointerfaces to determine – unambiguously and r eproducibly – the biological fate of NPs both in vitro and i n vivo. Deeper understanding of the nanobiointerfaces, using the overlooked factors, may accelerate clinical translation of nanobiotechnologies. The t alk also covers critical applications of nanobiointerfaces in cardiovascula r regenerative medicine, and defines how this knowledge can substantially r esolve some of the major issues in myocardial regeneration.
Password:<
/b> 477159
Join by Telephone:
US: +1
301 715 8592 or +1 312 626 6799 or +1 646 558 8656 or +1 253 215 8782 or +1
346 248 7799 or +1 669 900 9128
Meeting ID: 969 5670 6663
International numbers:
Skype for Business (Lync)
htt
ps://rutgers.zoom.us/skype/94925703570
NanoBio Interfaces: Opportunities and < i>Challenges of Protein Corona
N anoparticles (NPs) are becoming increasingly promising tools for medical di agnostics and therapeutics. Despite the advances in their biomedical applic ations and numerous publications, fewer than expected NPs have made it to c linical trials and even fewer have reached clinical practice. This wide gap between bench discoveries and clinical applications is mainly because of o ur limited understanding of the nanobiointerfaces. Although extensive studi es have been conducted to enhance our understanding of the nanobiointerface s, the literature remains unclear and contains conflicting information, eve n for seemingly identical NPs. The main goal of this talk is to introduce s ome of the existing “overlooked” factors at the nanobiointerfaces to determ ine – unambiguously and reproducibly – the biological fate of NPs both in&n bsp;vitro and in vivo. Deeper understanding of the nanobiointerfa ces, using the overlooked factors, may accelerate clinical translation of n anobiotechnologies. The talk also covers critical applications of nanobioin terfaces in cardiovascular regenerative medicine, and defines how this know ledge can substantially resolve some of the major issues in myocardial rege neration.
Zoom M
eeting Link: https://rutgers.zoom.us/j/96956706663?pwd=UENnNGdnRnhvcE5RUS9nWnMrMzN5Zz
09&from=addon
Meetin
g ID: 969 5670 6663
Password: 477159
Join by Telephone:
US: +1 301 715 8592 or +1 312 626 6799 or +1 646 558 8656
or +1 253 215 8782 or +1 346 248 7799 or +1 669 900 9128
Meeting ID: 969 5670 6663
International numbers:
Skype for Business (
Lync)
<
a href="https://rutgers.zoom.us/skype/94925703570" style="color: #cc0033; t
ext-decoration: none; font-family: Helvetica, Arial, FreeSans, sans-serif;
font-size: 14px; letter-spacing: normal; orphans: 2; text-align: start; tex
t-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-s
pacing: 0px; background-color: #f7f7f7;">https://rutgers.zoom.us/skype/94925703570&nbs
p;
Hosted by Professor KiBum Lee
DTSTAMP:20240328T161550 DTSTART:20210209T160000 DTEND:20210209T170000 SEQUENCE:0 TRANSP:OPAQUE END:VEVENT END:VCALENDAR